Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117203) titled 'The role and mechanism of gut microbiota in oxaliplatin-induced peripheral neuropathy' on Jan. 21.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Tongde Hospital of Zhejiang Province
Condition:
None
Intervention:
OIPN negative group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: OIPN negative group:15;OIPN positive group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307001
Disclaimer: Curated by HT Syndication....